On-Demand CME Videos

Advances in Diagnostic and Prognostic Testing in Cutaneous Melanoma: Online CME Activity


To find out the correct answer, click "Start Activity."

Why is it important to improve patient selection for SLNB surgical procedure? Select the best answer below.

a. Majority of patients that undergo the procedure are negative

b.  Reduce exposure to unnecessary anesthesia risks and surgical complications

c. Reduce healthcare costs

d. SLNB carries a false negative rate of almost 18%

e.  All of the above

This activity is supported by an educational grant from Castle Biosciences.


In order to ensure educational material is relevant, educational materials will expire after a certain time period. This course will be available for the following dates:

Release Date:

December 2, 2022

Expiration Date:

December 2, 2023

Learning Objectives

At the completion of this activity, participants should be better able to:

  • Summarize the epidemiology of malignant melanoma

  • Describe the current challenges of accurately diagnosing and predicting the behavior of malignant melanoma

  • Evaluate current and emerging data surrounding outcomes using these technologies

  • Outline current guideline recommendations regarding the implementation of these GEP technologies

Intended Audience
This activity has been designed for dermatologists, dermatology physician assistants, dermatology nurse practitioners, and other providers involved in the care of patients.
Aaron Farberg, MD

Bare Dermatology
Baylor Scott & White Health System
Dallas, TX

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Institute for Continuing Healthcare Education and CMEsquared. The Institute is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

The Institute for Continuing Healthcare Education designates this live and enduring activity for a maximum of 1 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures & Disclaimers


In accordance with the ACCME Standards for Commercial Support, balance, independence, objectivity, and scientific rigor are ensured in all CME activities. This requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with any ineligible companies. In addition, the content of this material has been approved by an independent peer reviewer. 

Disclosures are as follows:

Aaron S. Farberg, MD

Speakers’ Bureau or Honoraria: Novartis, Sanofi Regeneron, SUN Pharma, Galderma, Castle Biosciences, Janssen, Ortho Dermatologics, Pfizer 

The planners have disclosed that they have no relevant financial relationships with any Ineligible Company in the past 24 months.  

The Institute discloses that all relevant conflicts have been satisfactorily mitigated.


The leading platform for dermatology professionals to elevate patient care.

Contact Us


Subscribe now

Enter your email to get the latest updates.

© 2023 dermsquared | All Rights Reserved